• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子痫前期中血管生成因子与能量代谢的关系。

The Relationship between Angiogenic Factors and Energy Metabolism in Preeclampsia.

机构信息

Department of Obstetrics and Gynecology, Division of Maternal and Fetal Medicine, La Paz University Hospital, Paseo de la Castellana 261, 28046 Madrid, Spain.

Department of Clinical Chemistry, La Paz University Hospital, 28046 Madrid, Spain.

出版信息

Nutrients. 2022 May 23;14(10):2172. doi: 10.3390/nu14102172.

DOI:10.3390/nu14102172
PMID:35631313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9145768/
Abstract

Antiangiogenic factors are currently used for the prediction of preeclampsia. The present study aimed to evaluate the relationship between antiangiogenic factors and lipid and carbohydrate metabolism in maternal plasma and placenta. We analyzed 56 pregnant women, 30 healthy and 26 with preeclampsia (including early and late onset). We compared antiangiogenic factors soluble Fms-like Tyrosine Kinase-1 (sfLt-1), placental growth factor (PlGF), and soluble endoglin (sEng)), lipid and carbohydrate metabolism in maternal plasma, and lipid metabolism in the placenta from assays of fatty acid oxidation, fatty acid esterification, and triglyceride levels in all groups. Antiangiogenic factors sFlt-1, sFlt-1/PlGF ratio, and sEng showed a positive correlation with triglyceride, free fatty acid, and C-peptide maternal serum levels. However, there was no relationship between angiogenic factors and placental lipid metabolism parameters. Free fatty acids were predictive of elevated sFlt-1 and sEng, while C-peptide was predictive of an elevated sFlt1/PlGF ratio. The findings in this study generate a model to predict elevated antiangiogenic factor values and the relationship between them with different products of lipid and carbohydrate metabolism in maternal serum and placenta in preeclampsia.

摘要

抗血管生成因子目前用于预测子痫前期。本研究旨在评估母体血浆和胎盘抗血管生成因子与脂质和碳水化合物代谢之间的关系。我们分析了 56 名孕妇,30 名健康孕妇和 26 名子痫前期孕妇(包括早发型和晚发型)。我们比较了抗血管生成因子可溶性 fms 样酪氨酸激酶-1(sfLt-1)、胎盘生长因子(PlGF)和可溶性内皮素(sEng))、母体血浆中的脂质和碳水化合物代谢,以及所有组中脂肪酸氧化、脂肪酸酯化和甘油三酯水平的胎盘脂质代谢。抗血管生成因子 sFlt-1、sFlt-1/PlGF 比值和 sEng 与甘油三酯、游离脂肪酸和 C 肽呈正相关。然而,血管生成因子与胎盘脂质代谢参数之间没有关系。游离脂肪酸可预测 sFlt-1 和 sEng 升高,而 C 肽可预测 sFlt1/PlGF 比值升高。本研究的结果提出了一种模型,用于预测子痫前期母体血清和胎盘不同脂质和碳水化合物代谢产物中升高的抗血管生成因子值及其之间的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26b3/9145768/9553673b04fa/nutrients-14-02172-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26b3/9145768/9553673b04fa/nutrients-14-02172-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26b3/9145768/9553673b04fa/nutrients-14-02172-g001.jpg

相似文献

1
The Relationship between Angiogenic Factors and Energy Metabolism in Preeclampsia.子痫前期中血管生成因子与能量代谢的关系。
Nutrients. 2022 May 23;14(10):2172. doi: 10.3390/nu14102172.
2
Combining metformin and sulfasalazine additively reduces the secretion of antiangiogenic factors from the placenta: Implications for the treatment of preeclampsia.联合使用二甲双胍和柳氮磺胺吡啶可显著减少胎盘分泌的抗血管生成因子:对子痫前期治疗的启示。
Placenta. 2020 Jun;95:78-83. doi: 10.1016/j.placenta.2020.04.010. Epub 2020 Apr 25.
3
Difficulty of predicting early-onset super-imposed preeclampsia in pregnant women with hemodialysis due to diabetic nephropathy by serum levels of sFlt-1, PlGF, and sEng.血清可溶性 fms 样酪氨酸激酶 1(sFlt-1)、胎盘生长因子(PlGF)和可溶性内皮因子(sEng)水平预测糖尿病肾病行血液透析孕妇早发重叠子痫前期的难度。
CEN Case Rep. 2020 May;9(2):101-105. doi: 10.1007/s13730-019-00435-y. Epub 2019 Nov 14.
4
Similar Pro- and Antiangiogenic Profiles Close to Delivery in Different Clinical Presentations of Two Pregnancy Syndromes: Preeclampsia and Fetal Growth Restriction.在两种妊娠综合征(子痫前期和胎儿生长受限)的不同临床表现中,临近分娩时的促血管生成和抗血管生成谱相似。
Int J Mol Sci. 2023 Jan 4;24(2):972. doi: 10.3390/ijms24020972.
5
Angiogenic Imbalance as a Contributor of Preeclampsia.血管生成失衡是子痫前期的一个促成因素。
Curr Pharm Biotechnol. 2018;19(10):797-815. doi: 10.2174/1389201019666180925115559.
6
Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.可溶性 fms 样酪氨酸激酶-1 和可溶性内皮糖蛋白在 HIV 相关子痫前期中的作用。
Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):100-5. doi: 10.1016/j.ejogrb.2013.05.021. Epub 2013 Jun 24.
7
Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.正常妊娠和子痫前期妊娠中可溶性内皮糖蛋白、可溶性fms样酪氨酸激酶受体-1以及胎盘生长因子的胎盘产生及表达
J Clin Endocrinol Metab. 2008 Jan;93(1):260-6. doi: 10.1210/jc.2007-1550. Epub 2007 Oct 23.
8
Sulfasalazine reduces placental secretion of antiangiogenic factors, up-regulates the secretion of placental growth factor and rescues endothelial dysfunction.柳氮磺胺吡啶减少胎盘分泌抗血管生成因子,上调胎盘生长因子的分泌并挽救血管内皮功能障碍。
EBioMedicine. 2019 Mar;41:636-648. doi: 10.1016/j.ebiom.2019.02.013. Epub 2019 Feb 26.
9
Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy.胎盘生长因子可逆转高血压妊娠中血管和胎盘基质金属蛋白酶-2 和基质金属蛋白酶-9 的减少,以及基质金属蛋白酶-1 和基质金属蛋白酶-7 和 I 型和 IV 型胶原的增加。
Am J Physiol Heart Circ Physiol. 2018 Jul 1;315(1):H33-H47. doi: 10.1152/ajpheart.00045.2018. Epub 2018 Mar 23.
10
The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.子痫前期患者循环内皮素-1、可溶性 fms 样酪氨酸激酶-1 与可溶性内皮糖蛋白的关系。
J Hum Hypertens. 2012 Apr;26(4):236-41. doi: 10.1038/jhh.2011.29. Epub 2011 Mar 31.

引用本文的文献

1
Role of vitamin D in the pathogenesis of early-onset preeclampsia: a narrative review.维生素D在早发型子痫前期发病机制中的作用:一篇叙述性综述。
Front Nutr. 2025 Jun 18;12:1598691. doi: 10.3389/fnut.2025.1598691. eCollection 2025.
2
Vascular Inflammatory Genes as Predictors of Preeclampsia: A Systematic Review.血管炎症基因作为子痫前期的预测指标:一项系统综述
J Pharm Bioallied Sci. 2024 Dec;16(Suppl 5):S4324-S4326. doi: 10.4103/jpbs.jpbs_1134_24. Epub 2025 Jan 30.
3
PPARγ alleviates preeclampsia development by regulating lipid metabolism and ferroptosis.

本文引用的文献

1
Clinical risk factors for preeclampsia in twin pregnancies.双胎妊娠子痫前期的临床危险因素。
PLoS One. 2021 Apr 15;16(4):e0249555. doi: 10.1371/journal.pone.0249555. eCollection 2021.
2
Dyslipemias and pregnancy, an update.血脂异常与妊娠:最新进展。
Clin Investig Arterioscler. 2021 Jan-Feb;33(1):41-52. doi: 10.1016/j.arteri.2020.10.002. Epub 2020 Dec 9.
3
Placental Compartmentalization of Lipid Metabolism: Implications for Singleton and Twin Pregnancies.胎盘脂质代谢的分隔化:对单胎和双胎妊娠的影响。
过氧化物酶体增殖物激活受体 γ 通过调节脂质代谢和铁死亡缓解子痫前期的发生发展。
Commun Biol. 2024 Apr 9;7(1):429. doi: 10.1038/s42003-024-06063-2.
4
Pre-pregnancy body mass index combined with peripheral blood PLGF, DCN, LDH, and UA in a risk prediction model for pre-eclampsia.孕前体质量指数联合外周血 PLGF、DCN、LDH 和 UA 在子痫前期风险预测模型中的应用。
Front Endocrinol (Lausanne). 2024 Jan 8;14:1297731. doi: 10.3389/fendo.2023.1297731. eCollection 2023.
5
Decreased Fatty Acid Oxidation Gene Expression in Pre-Eclampsia According to the Onset and Presence of Intrauterine Growth Restriction.子痫前期中脂肪酸氧化基因表达的降低与宫内生长受限的发生和存在有关。
Nutrients. 2023 Sep 6;15(18):3877. doi: 10.3390/nu15183877.
6
Growth-Restricted Fetuses and Offspring Reveal Adverse Sex-Specific Metabolic Responses in Preeclamptic Mice Expressing Human sFLT1.生长受限的胎儿和后代揭示了表达人可溶性血管内皮生长因子受体1的子痫前期小鼠中不良的性别特异性代谢反应。
Int J Mol Sci. 2023 Apr 7;24(8):6885. doi: 10.3390/ijms24086885.
7
Literature Review: The sFlt1/PlGF Ratio and Pregestational Maternal Comorbidities: New Risk Factors to Predict Pre-Eclampsia.文献综述:sFlt1/PlGF 比值与孕前母体合并症:预测子痫前期的新危险因素。
Int J Mol Sci. 2023 Apr 4;24(7):6744. doi: 10.3390/ijms24076744.
Reprod Sci. 2021 Apr;28(4):1150-1160. doi: 10.1007/s43032-020-00385-2. Epub 2020 Nov 10.
4
Placental lipid metabolism in preeclampsia.子痫前期的胎盘脂质代谢。
J Hypertens. 2021 Jan;39(1):127-134. doi: 10.1097/HJH.0000000000002596.
5
Lipid profiling in maternal and fetal circulations in preeclampsia and fetal growth restriction-a prospective case control observational study.子痫前期和胎儿生长受限孕妇及胎儿循环中脂质谱特征:一项前瞻性病例对照观察性研究。
BMC Pregnancy Childbirth. 2020 Jan 30;20(1):61. doi: 10.1186/s12884-020-2753-1.
6
Cross-Talk between Oxidative Stress and Inflammation in Preeclampsia.子痫前期中氧化应激与炎症的相互作用。
Oxid Med Cell Longev. 2019 Nov 4;2019:8238727. doi: 10.1155/2019/8238727. eCollection 2019.
7
Increased BMI has a linear association with late-onset preeclampsia: A population-based study.体重指数升高与晚发型子痫前期呈线性相关:基于人群的研究。
PLoS One. 2019 Oct 17;14(10):e0223888. doi: 10.1371/journal.pone.0223888. eCollection 2019.
8
Abnormal expression and clinical significance of 25-hydroxyvitamin D and sFlt-1 in patients with preeclampsia.子痫前期患者25-羟维生素D和可溶性血管内皮生长因子受体-1的异常表达及临床意义
J Int Med Res. 2019 Oct;47(10):4673-4682. doi: 10.1177/0300060519860979. Epub 2019 Sep 12.
9
Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes.可溶性内皮糖蛋白作为子痫前期、其严重程度和不良结局发生的标志物。
Hypertension. 2019 Oct;74(4):991-997. doi: 10.1161/HYPERTENSIONAHA.119.13348. Epub 2019 Aug 26.
10
Pre-eclampsia: pathophysiology and clinical implications.子痫前期:病理生理学与临床意义。
BMJ. 2019 Jul 15;366:l2381. doi: 10.1136/bmj.l2381.